Juno Therapeutics, Inc. 8725 W. Higgins Road, Suite 290 Chicago, IL 60631Side Letter Agreement • November 17th, 2014 • Juno Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 17th, 2014 Company Industry JurisdictionThis Amended and Restated Investors’ Rights Agreement (this “Agreement”) is dated as of November 21, 2013, and is between JUNO THERAPEUTICS, INC., a Delaware corporation (f/k/a FC Therapeutics, Inc.) (the “Company”), and the persons and entities listed on Exhibit A (each, an “Investor” and collectively, the “Investors”).
Juno Therapeutics, Inc. 8725 W. Higgins Road, Suite 290 Chicago, IL 60631Side Letter Agreement • October 24th, 2014 • Juno Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledOctober 24th, 2014 Company Industry JurisdictionThis Amended and Restated Investors’ Rights Agreement (this “Agreement”) is dated as of November 21, 2013, and is between JUNO THERAPEUTICS, INC., a Delaware corporation (f/k/a FC Therapeutics, Inc.) (the “Company”), and the persons and entities listed on Exhibit A (each, an “Investor” and collectively, the “Investors”).